The library subject alerts have been retired in favour of a more tailored alert service. 

If you would like to receive an alert targeted to your interests, please submit a Subject alert request.


Acute Hepatitis E virus Subtype 3e Infection with Prolonged Jaundice Improved with Inchinkoto Internal Medicine. 2025;64(23):3366–3371
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40436756

Association of histologic and clinical activity with major adverse cardiovascular events in patients with inflammatory bowel disease: A cohort study  Journal of Internal Medicine. 2025;298(6):697–710
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41131885

An Autopsy Case of a Desmoplastic Small Round Cell Tumor with a Rapid Fatal Outcome due to Diffuse Cystic Liver Metastases Internal Medicine. 2025;64(23):3380–3386
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40467499

Cause-specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007-22: a retrospective cohort study  Medical Journal of Australia. 2025;223(9):473–483
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40931480

Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk  Journal of Internal Medicine. 2025;298(6):626–636
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41088845

Early-onset Colorectal Cancer in a Patient with Li-Fraumeni Syndrome: A Case Series and Literature Review  Internal Medicine. 2025;64(22):3244–3251
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40222933

Escherichia coli Sternoclavicular Septic Arthritis Secondary to Colon Cancer-associated Bacteremia  Internal Medicine. 2025;64(22):3306–3310
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40335306

Exploring the evidence that supports the benefits of the multidisciplinary team in inflammatory bowel disease  American Journal of Medicine. 2025;138(12):1724–1733.e1
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40818708

Heyde Syndrome Complicated by Alcoholic Liver Cirrhosis in Which Aortic Valve Stenosis Was Diagnosed due to Gastrointestinal Bleeding  Internal Medicine. 2025;64(23):3359–3365
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40399089

Importance of Vaccine Adjuvants: A Comparative Study of Antibody Acquisition Rates and Levels Before and After Adjuvant Change in the Hepatitis B Vaccine  Internal Medicine. 2025;64(21):3103–3106
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41183895

In adults aged 45 to 49 y, active screening choices via patient portal reduced screening rates vs. mailed FIT at 6 mo Annals of Internal Medicine. 2025;178(11):Jc125
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41183331

Latent Tubulointerstitial Nephritis with IgM-positive Plasma Cells Uncovered in a Case of IgA Nephropathy and Primary Biliary Cholangitis: Clinical and Histological Insights  Internal Medicine. 2025;64(22):3266–3271
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40368788

Low positive and borderline negative transglutaminase antibody levels are frequently associated with a coeliac disease diagnosis  Journal of Internal Medicine. 2025;298(6):617–625
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40994413

Methylprednisolone-induced Anaphylaxis in Acute Hepatitis B: A Case Report and Literature Review  Internal Medicine. 2025;64(22):3232–3237
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40368793

Non-coeliac gluten sensitivity  Lancet. 2025;406(10518):2494–2508
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41138740

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment  New England Journal of Medicine. 2025;393(18):1796–1806
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40960239

A practical approach to the diagnosis and management of hepatic encephalopathy  American Journal of Medicine. 2026;139(1):14–23.e4
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40902920

Rare Case of Severe Pancreatitis Induced by Encorafenib and Cetuximab in BRAF V600E-Positive Colorectal Cancer  Internal Medicine. 2025;64(22):3252–3256
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40301039

Risk of gastrointestinal rebleeding in direct oral anticoagulant-treated population  Postgraduate Medical Journal. 2025;101(1202):1361–1369
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40639323

SGLT2 inhibitors and cardiovascular outcomes in metabolic dysfunction-associated steatotic liver disease: A real-world retrospective cohort study  American Journal of Medicine. 2026;139(1):57–65.e1
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40571041

Starting hepatitis C treatment during acute care hospitalizations: A qualitative study of barriers and facilitators Journal of Hospital Medicine. 2025;20(12):1323–1331
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40500919

Statin use for primary prevention of cardiovascular disease reduces the risk of incident IBD: A population-based cohort study  Journal of Internal Medicine. 2025;298(6):686–696
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41131862

Steroid-responsive Encephalopathy with a Primary CMV Infection Complicated by Enteritis in a Young Woman with Ulcerative Colitis  Internal Medicine. 2025;64(23):3443–3446
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40436755

Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial  Lancet. 2025;406(10517):2360–2370
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41130252